FDA wins experimental drugs decision

Share this article:
The Washington, DC Court of Appeals has ruled in the FDA's favor that terminally ill patients have no "fundamental right 'deeply rooted in this nation's history and tradition'" to have access to experimental drugs. Late last year, the FDA won a petition to have the full US Court of Appeals for DC reconsider a ruling that mentally competent terminally ill patients should have access to post-phase I investigational drugs if there are no government-approved alternative treatments available.

The court agreed 2-1 that patients have a right to unapproved drugs, and said an earlier court opinion had erred.

Speaking on an FDLI audio conference later, FDA deputy chief counsel Jeff Senger said that accessing these drugs is not a fundamental constitutional right and thus the FDA needs only a “rational” basis for its regulatory drug development policy.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?